The bull market is seeing the equivalent of its first gray hairs.

Just take a look at the blast of merger activity Tuesday. Three big drug companies engaged in a swap of assets that reshapes a chunk of that industry's landscape, and an activist joined forces with serial acquirer Valeant to make a $46 billion run at Allergan, the company that makes Botox.